Dr Tony Wood

Tony Wood is the chief scientific officer at GSK. He started his career in the pharmaceutical industry in 1992 as a medicinal chemist at Pfizer, after a PhD in organic chemistry at Newcastle University and a postdoc at Imperial College. After 25 years at Pfizer, he moved to GSK in 2017, and was made CSO in 2022.
Throughout his career, he has been at the forefront of the development and application of science and technology in the pharmaceutical industry. As a medicinal chemist, he invented the anti-HIV drug maraviroc (Celsentri/Selzentry), the first host-targeted HIV medicine, and made substantial contributions to many more.
Since leaving the lab, he has driven significant transformations in the way new medicines are identified and developed at both Pfizer and GSK. This includes the application of technologies such as human genetics, functional genomics, patient phenotyping and the predictive design of molecules.
As well as receiving several awards for medicinal chemistry and maraviroc, he is both a Fellow and an Honorary Fellow of the Royal Society of Chemistry, and a Fellow of the Academy of Medical Sciences.